Cargando…

The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat

The primary headache disorders include migraine, which is one of the most frequent neurological disorders, which influences more than 14% of the whole population. Despite the research efforts, its exact pathomechanism is not fully revealed, but evidence points to the role of glutamate and its recept...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagy-Grócz, Gábor, Laborc, Klaudia F., Veres, Gábor, Bajtai, Attila, Bohár, Zsuzsanna, Zádori, Dénes, Fejes-Szabó, Annamária, Spekker, Eleonóra, Vécsei, László, Párdutz, Árpád
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469907/ https://www.ncbi.nlm.nih.gov/pubmed/28659861 http://dx.doi.org/10.3389/fneur.2017.00278

Ejemplares similares

Corrigendum: The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
por: Nagy-Grócz, Gábor, et al.
Publicado: (2020)

Chronic 17β-estradiol pretreatment has pronociceptive effect on behavioral and morphological changes induced by orofacial formalin in ovariectomized rats
por: Fejes-Szabó, Annamária, et al.
Publicado: (2018)

Trigeminal activation patterns evoked by chemical stimulation of the dura mater in rats
por: Laborc, Klaudia Flóra, et al.
Publicado: (2020)

Effect of dural inflammatory soup application on activation and sensitization markers in the caudal trigeminal nucleus of the rat and the modulatory effects of sumatriptan and kynurenic acid
por: Spekker, Eleonóra, et al.
Publicado: (2021)

Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
por: Nagy-Grócz, Gábor, et al.
Publicado: (2017)

Estradiol Treatment Enhances Behavioral and Molecular Changes Induced by Repetitive Trigeminal Activation in a Rat Model of Migraine
por: Spekker, Eleonóra, et al.
Publicado: (2022)

Kynurenine Metabolites and Migraine: Experimental Studies and Therapeutic Perspectives
por: Fejes, Annamária, et al.
Publicado: (2011)

Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
por: Tanaka, Masaru, et al.
Publicado: (2020)

All Roads Lead to the Gut: The Importance of the Microbiota and Diet in Migraine
por: Spekker, Eleonóra, et al.
Publicado: (2023)

Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
por: Bohár, Zsuzsanna, et al.
Publicado: (2015)

Neurotransmitter and tryptophan metabolite concentration changes in the complete Freund’s adjuvant model of orofacial pain
por: Cseh, Edina K., et al.
Publicado: (2020)

The Tryptophan-Kynurenine Metabolic System Is Suppressed in Cuprizone-Induced Model of Demyelination Simulating Progressive Multiple Sclerosis
por: Polyák, Helga, et al.
Publicado: (2023)

Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
por: Zádor, Ferenc, et al.
Publicado: (2019)

Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression
por: Zádor, Ferenc, et al.
Publicado: (2021)

Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan–Kynurenine Metabolic System
por: Tanaka, Masaru, et al.
Publicado: (2022)

Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines
por: Zádori, Dénes, et al.
Publicado: (2011)

Cuprizone markedly decreases kynurenic acid levels in the rodent brain tissue and plasma
por: Polyák, Helga, et al.
Publicado: (2021)

EHMTI-0189. Tryptophan-kynurenine metabolism in migraine patients
por: Majláth, Z, et al.
Publicado: (2014)

Kynurenic Acid and Its Analogs Are Beneficial Physiologic Attenuators in Bdelloid Rotifers
por: Datki, Zsolt, et al.
Publicado: (2019)

Distinct cytokine patterns may regulate the severity of neonatal asphyxia—an observational study
por: Bajnok, Anna, et al.
Publicado: (2017)

Non-motor Behavioral Alterations of PGC-1α-Deficient Mice – A Peculiar Phenotype With Slight Male Preponderance and No Apparent Progression
por: Szalardy, Levente, et al.
Publicado: (2018)

Cerebellar Predominant Increase in mRNA Expression Levels of Sirt1 and Sirt3 Isoforms in a Transgenic Mouse Model of Huntington’s Disease
por: Salamon, Andras, et al.
Publicado: (2020)

Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research
por: Spekker, Eleonóra, et al.
Publicado: (2021)

The assessment of possible gender-related effect of endogenous striatal alpha-tocopherol level on MPTP neurotoxicity in mice
por: Nánási, Nikolett, et al.
Publicado: (2020)

Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection
por: Sas, Katalin, et al.
Publicado: (2018)

Commentary: The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
por: Valença, Marcelo Moraes
Publicado: (2017)

White matter disintegration in cluster headache
por: Szabó, Nikoletta, et al.
Publicado: (2013)

Exploring the Tryptophan Metabolic Pathways in Migraine-Related Mechanisms
por: Körtési, Tamás, et al.
Publicado: (2022)

TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine
por: Spekker, Eleonóra, et al.
Publicado: (2022)

Kynurenines, neurodegeneration and Alzheimer’s disease
por: Kincses, Zsigmond Tamas, et al.
Publicado: (2010)

Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway
por: Tanaka, Masaru, et al.
Publicado: (2021)

Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
por: Tanaka, Masaru, et al.
Publicado: (2021)

Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway
por: Boros, Fanni A., et al.
Publicado: (2019)

Genetic epidemiological characteristics of a Hungarian subpopulation of patients with Huntington’s disease
por: Despotov, Katalin, et al.
Publicado: (2021)

Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy—Kynurenines Are Important Players
por: Sandi, Dániel, et al.
Publicado: (2021)

Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
por: Biernacki, Tamás, et al.
Publicado: (2020)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Release of PACAP-38 in episodic cluster headache patients – an exploratory study
por: Tuka, Bernadett, et al.
Publicado: (2016)

Differential Effects of Hypothermia and SZR72 on Cerebral Kynurenine and Kynurenic Acid in a Piglet Model of Hypoxic–Ischemic Encephalopathy
por: Domoki, Ferenc, et al.
Publicado: (2023)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_drk4govpp1v0rca74seb4svr19